DESCRIPTION OF BUSINESS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Narrative (Details) $ in Millions	12 Months Ended
	Dec. 31, 2025 USD ($)	Dec. 31, 2024 USD ($) facility segment	Dec. 31, 2023 USD ($)	Dec. 31, 2022 USD ($)	Mar. 28, 2024 USD ($)	Feb. 15, 2024 USD ($)	Feb. 15, 2024 CAD ($)
Class of Stock [Line Items]
Number of pharmaceutical manufacturing facilities | facility		3
FDIC guaranteed amount		$ 250,000
Impairment loss related to property and equipment recognized		0	$ 0	$ 0
Assets held for sale		0	8,020,000
Intangible asset impairment charge		$ 3,600,000	0	100,000
Impairment, Intangible Asset, Finite-Lived, Statement of Income or Comprehensive Income [Extensible Enumeration]		Intangible asset impairment charge
Impairment of intangible assets, indefinite-lived		$ 4,000,000.0	0	0
Impairment, Intangible Asset, Indefinite-Lived (Excluding Goodwill), Statement of Income or Comprehensive Income [Extensible Enumeration]		Intangible asset impairment charge
Number of reporting units | segment		3
Goodwill, impairment loss		$ 0	0	$ 0
Forecast | Accrued Licensor Payments
Class of Stock [Line Items]
Collaborative arrangement royalty payable on net revenue revenue threshold	$ 70,000,000
Disposal Group, Held-for-Sale, Not Discontinued Operations | Oakville, Ontario Former Manufacturing Facility
Class of Stock [Line Items]
Consideration					$ 13,500,000	$ 14,200,000	$ 19.2
Performance Shares
Class of Stock [Line Items]
Vesting period		3 years
Minimum
Class of Stock [Line Items]
Useful life		7 years
Maximum
Class of Stock [Line Items]
Useful life		12 years
CANADA
Class of Stock [Line Items]
Assets held for sale			$ 8,000,000.0